BioNTech founders to leave, form new mRNA-focused company
LONDON — The co-founders of the Covid-19 vaccine developer BioNTech plan to leave the biotech to start a new mRNA-focused company, the German drugmaker said Tuesday.
Ugur Sahin and Özlem Türeci, who are married, will transition to the as-of-yet unnamed company by the end of the year, with a focus on researching and developing next-generation mRNA medicines.
BioNTech will be giving certain rights to its mRNA technology to the new company, while picking up a minority stake in it.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
First Appeared on
Source link
